Rosebank Advisors

What we do

We help manufacturers, funders, governments and non-profits move medicines, health services and technologies into the markets that need them most — and are least often designed for. That work spans the full path to access: understanding demand, shaping the evidence and the value case, redesigning how products are procured and financed, pricing for affordability, and building the partnerships that make introduction hold once the launch is over.

Much of it comes down to money and incentives. Getting a product registered is rarely the binding constraint; paying for it year after year usually is. So we work on the financing side as seriously as the clinical one — helping governments unlock fiscal space, aligning what buyers, suppliers and funders are each rewarded for, and putting the savings back into systems that then hold more.

Our focus is low- and middle-income markets, with deep experience across West, East and Southern Africa. We work in small, senior teams and stay close to the detail.

Who we are

Jorge Quevedo · Founder

Twenty-five years at the point where public health, markets and finance meet.

Jorge spent more than 14 years living and working in Africa with the Clinton Health Access Initiative. As Country Director for South Africa, he led a multidisciplinary team of more than 110 people and advised senior government leaders on bringing new drugs, diagnostics and interventions to scale. Structuring smarter government procurement helped deliver more than $2.5 billion in savings across product classes, freeing resources to reach more patients.

He has mobilised more than $150 million in funding, helped channel $200 million in public-private support for South Africa’s early COVID-19 response, and supported governments through Global Fund and US Government negotiations. In Mozambique, his teams field-validated point-of-care CD4, viral load and early infant HIV diagnostics — work published in The Lancet, AIDS and PLoS ONE.

Services